ALX Oncology Holdings Inc.
ALXO
$1.36
$0.043.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.01M | -116.57M | -130.02M | -134.85M | -151.16M |
| Total Depreciation and Amortization | 769.00K | 840.00K | 869.00K | 872.00K | 865.00K |
| Total Amortization of Deferred Charges | 277.00K | 271.00K | 268.00K | 265.00K | 260.00K |
| Total Other Non-Cash Items | 18.92M | 22.58M | 23.46M | 24.23M | 23.83M |
| Change in Net Operating Assets | -9.16M | -12.61M | -3.23M | -12.43M | -3.34M |
| Cash from Operations | -97.21M | -105.49M | -108.65M | -121.91M | -129.54M |
| Capital Expenditure | -223.00K | -316.00K | -359.00K | -447.00K | -535.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.76M | 109.15M | 87.79M | 86.70M | 36.94M |
| Cash from Investing | 104.54M | 108.84M | 87.43M | 86.26M | 36.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -780.00K | -978.00K | -959.00K | -827.00K | -814.00K |
| Issuance of Common Stock | 61.00K | 594.00K | 1.75M | 1.98M | 65.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 731.00K | 806.00K | 27.01M | 29.66M | 24.90M |
| Cash from Financing | 12.00K | 422.00K | 27.80M | 30.82M | 89.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.34M | 3.77M | 6.57M | -4.84M | -3.48M |